NCT07122245Recruiting
Demographics of Lung Cancer in Females
Demographics of Lung Cancer in Female Patients: A Retrospective Based Analysis
Source: ClinicalTrials.gov · Last updated 18 Aug 2026
Brief summary (registry, in English)
Lung cancer has been the most common and fatal type of cancer; indeed worldwide incidence of lung cancer is alarming. It is considered a leading cause of cancer- related deaths among males and females due to environmental pollution, occupational exposure, genetic susceptibility, increasing number of smokers and others.
- Status (registry)
- Recruiting
- Study type
- Observational
- Enrollment
- 300 (estimated)
- First submitted
- 7 Aug 2025
- Start date
- 7 Aug 2025
- Primary completion date
- 7 Dec 2026
- Lead sponsor
- Mansoura University Hospital
- Diseases
- Lung cancer, Childhood cancers
- NCT number
- NCT07122245
What you commit to
- Study type: Observational
- Planned participants: 300
- From 7 Aug 2025 to the primary completion date, 7 Dec 2026
- 1 site in 1 country
- Visits and tests: ask the trial team, the registry does not list them
Built from the registry fields of ClinicalTrials.gov. It describes the study, not your situation.
Who cannot take part
Copied verbatim from ClinicalTrials.gov and grouped by topic. Only the trial team decides who can take part.
Other
- lung metastasis ( not primary bronchogenic carcinoma)
Who the study is looking for
- All female patients presented with bronchogenic carcinoma patients and diagnosed at chest diseases department, Oncology Center Mansoura University (OCMU) in last 10 years.
Sex: Female · Does not accept healthy volunteers
Sites (1)
Sites in registry order. Pick your city on the disease page to sort them by distance.
| Site | City | Country | Site status |
|---|---|---|---|
| Mohamed AbdElmoniem Coordinator of this site? Confirm its status | Al Mansurah | Egypt | Recruiting |
This page is information, not medical advice. Discuss any trial with your doctor.